ConductScience.org, home

Gene · 9869

NIH grants1,953

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSETDB1 papersNewest fiscal year
P30CA030199Cancer Center Support Grant (CCSG)22025
P30CA033572Cancer Center Support Grant22025
P30CA046934University of Colorado Cancer Center Support Grant22025
P30CA054174Mays Cancer Center at UT Health SA22025
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital22025
P30DK050306Center for Molecular Studies in Digestive and Liver Diseases22025
P30DK084567Mayo Center for Cell Signaling in Gastroenterology22025
P30GM124165NE-CAT: A Resource for Advanced Macromolecular Crystallography22025
P50HD103524Intellectual and Developmental Disabilities Research Center22025
R01AI118891Viral modulation of epitranscriptomic mechanisms22025
R01AI148416Histone Variant H3.3 as a Transcription Rheostat in the Immune System22025
R01AI150931Manipulation of host factors that promote HCMV latency22025
R01AI153348HCMV GPCR functions during latency and reactivation22025
R01AR043369MITF from control of pigmentation to melanoma risk22025
R01AR072304Therapeutic strategies for treatment of giant congenital melanocytic nevi22025
R01CA202919Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer22025
R01CA248037Regulation of oncogenic Akt ubiquitination and activation by diverse mechanisms in cancer22025
R01CA260691Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma22025
R01CA271497The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia22025
R01HG003143Structural Annotation of the Human Genome22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/9869/grants?page=3